ARCHIVES

Investment is the seed of economic progress. Wherever it is planted in an appropriate way, it grows and gives us incalculable benefits. Health intervention and technology are the same for national health improvement. They promote citizen’s quality of life and longevity. But how do we know which medical alternatives should be invested in for the […]

On January 28, 2020, PMAC 2020: Accelerating the Progress Towards UHC officially started with side meetings, with one of the very first ones hosted by Health Intervention and Technology Assessment Program (HITAP), titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Universal Health Coverage (UHC) Dialogue”. This session explored the use of health technology […]

IMPRESSIONS We are very honored to have participated in the Health Technology Assessment (HTA) training and symposium. We have seen interesting presentations ranging from economic valuation methods to the introduction of HTA in countries like Japan, Thailand, South Korea, the Philippines and Singapore. Through the shared modules, we realize that economic evaluation in health is […]

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this event was supported by the Access and Delivery Partnership (ADP) grant to the Health Intervention […]

In October 2019, the Health Intervention and Technology Assessment Program (HITAP) and the National Health Foundation (NHF), two partners in the Asia Health Technology Assessment (HTA) consortium, were thrilled to take an 8000 km trip to Rwanda to talk all things ‘priority setting’ at a workshop in Kigali, the country’s capital. The two-day workshop titled […]

A call for case studies was circulated in September 2018 for real life examples of Best Buys, Wasted Buys and Contestable Buys in low- and middle-income countries. 58 case studies from 30 countries were submitted and one of the chosen feature case studies was authored by Pempa from Health Technology Assessment Program, Bhutan. We were […]

We grabbed 5 minutes with Peter Smith[1], co-author of Chapter 8 titled Cross-Sectoral Policies to Address Non-Communicable Diseases to find out what this chapter entails.               Q: Why is cross-sectoral action important for Non-Communicable Disease (NCD) prevention and what are the key challenges? PS: The importance for NCDs of ‘social determinants’, such as education and […]

We sat down with the David Kim (DK), Rachel Bacon (RB) and Peter Neumann (PN)[1] who are the authors of Chapter 6 titled Assessing the Transferability of Economic Evaluations: A Decision Framework, to get a sneak peak into Chapter 6.   Q : Thank you for joining us today, can you first tell us why […]